NervGen Pharma
NGEN · TSX
$1.43+$0.01 (+0.70%)TodayMarket closed ·
Prev close $1.42
Who owns NGEN
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 23.6% of NGEN’s shares.
- PFP Biosciences Holdings LLC13.6%
- Empery Asset Management, L.P.3.7%
- Rock Springs Capital Management LP1.1%
- Punnett, Harold1.1%
- Next 6 largest institutions4.0%
- All other shareholders76.4%
| Holder | Shares | % of shares |
|---|---|---|
| PFP Biosciences Holdings LLC | 14.69M | 13.65% |
| Empery Asset Management, L.P. | 4.00M | 3.72% |
| Rock Springs Capital Management LP | 1.21M | 1.12% |
| Punnett, Harold | 1.18M | 1.09% |
| Dafna Capital Management, LLC | 1.05M | 0.98% |
| Ghisallo Capital Management LLC | 1.00M | 0.93% |
| Armistice Capital LLC | 678.00K | 0.63% |
| LMR Partners LLP | 600.00K | 0.56% |
| Bayley (Brian E) | 565.00K | 0.52% |
| Marshall Wace LLP | 435.96K | 0.41% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 67.45K | 0.06% |
Short interest
Settled Sep 30, 2026
- Shares short
- 5.83M
- Days to cover
- 11.29
- % of shares outstanding
- 5.42%
- Average daily volume
- 516.44K
- Change since last report
- +6.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.